RBC Capital Maintains Outperform on Celestica, Raises Price Target to $33
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Maxim Matushansky has maintained an Outperform rating on Celestica (NYSE:CLS) and increased the price target from $30 to $33.
November 30, 2023 | 3:20 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
RBC Capital analyst Maxim Matushansky reaffirms an Outperform rating on Celestica and raises the price target from $30 to $33, indicating a positive outlook on the stock.
The increase in price target by a reputable analyst typically signals a bullish perspective on the stock, suggesting that the analyst expects the stock to perform well in the near term. This can often lead to increased investor confidence and a potential rise in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100